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Abstract 
With a widespread use of nanomaterials in various manufacturing applications including 
consumer goods, semiconductor industry and pharmaceuticals, the safety of Engineering 
Nanomaterials (ENs) is a vital area of research. It is extremely important to analyze the risks 
posed by ENs in order to optimize design and/or control their use. The overarching goal of this 
work is to understand the cytotoxicity and cellular uptake potential of specific EN of well-
characterized physicochemical properties. Towards this objective, the specific aims of this 
project are to (a) comprehensively characterize the physical and chemical properties of starting 
ENs, (b) study their dose and time-course cytotoxic responses using cell viability assays and (c) 
assess cellular uptake of nanomaterials in mammalian cell types. Three nanomaterials were 
studied in this work - gold nanorods, zinc oxide and silica nanoparticles. The mammalian cell 
types used include 3T3 fibroblasts, neuronal PC12 and Normal Human Bronchial Epithelial 
(NHBE) cells. The extent of toxicity on these cell lines is studied by first characterizing the ENs 
using XRD, DLS and SEM analysis to determine physical and chemical properties prior to 
introduction. Next, cytotoxicity response is acquired using viability assay studies such as MTT 
and LDH assay. This analysis is further substantiated by using SEM and confocal microscopy to 
correlate dose-dependent cytotoxicity to morphological changes. Lastly, cellular uptake of the 
nanomaterials is investigated. Toxicity of nanomaterials is found to increase with concentration 
and is dependent on the properties of the material and the target species. 
  
3 
 
CHAPTER 1 
Introduction 
1.1 Objective  
 The overarching objective of this project is to understand cytotoxicity and cellular uptake 
of engineered nanomaterials (ENs) with different physical and chemical properties. Towards this 
objective, nanomaterials with different composition, size, and concentrations were studied at 
different time points ranging from 2-14 days after 1 day acute exposure to the nanomaterial.  
Nanotechnology has become a major scientific endeavor in the last decade. The advent of 
nanotechnology is considered the one of biggest engineering revolution. Ramifications of this 
new technology promise to reengineer the man-made world, molecule by molecule, by making 
commercially-viable products from machines to medicine. Nanotechnology is no longer just a 
large government research project but now products are moving out of the lab, into the market, 
and onto store shelves at an accelerating rate (1). The worldwide market for products produced 
using nanotechnology is estimated to reach US$1  trillion by 2015 (2). The most commercially 
important nanomaterials include metal oxides, such as silica, titanium oxide, alumina oxide, iron 
oxides, zinc oxide, cerium oxide and zirconia. These engineered metal-oxide nanoparticles are 
attractive for a large variety of applications such as catalysis, sensors, (photo)electronic 
materials, and environmental remediation, due to their unique crystal morphology and superior 
mechanical, electrical, magnetic, optical and adsorption properties (2) (3). These nanomaterials 
offer great technological advantages but their risks to human health are not completely 
understood and still under discussion.  
In reality, every organism on Earth continuously encounters nanometer-sized entities. 
The vast majority causes little to no ill effect, and goes unnoticed, but occasionally an intruder 
will cause appreciable harm to the organism (4). There are a lot of in vitro and in vivo studies 
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done for the same but even then the risks remain unclear. Because of the huge diversity and the 
number of nanomaterials available many studies are done in vitro in order to limit the cost. But 
even then the progress is slow, and there are at present no standard methods for testing, which 
makes the toxicity testing a challenge. Therefore, the goal of this project is to attempt to 
understand the cytotoxicity of selected nanomaterials. The specific aims of this project are to (a) 
characterize the selected nanomaterials, (b) analyze their cytotoxicity on different cell lines by 
using viability assays, and (c) to study the cellular uptake of these nanomaterials.  
1.2 Motivation 
 Near infinite number of Engineered Nanomaterials (ENs) can be generated from any 
metal, non-metal and organic compounds with a defined size, structure and shape. And it is very 
difficult to know the potential health effects of all these materials. There are loads of parameters 
that can vary and affect the behavior of the material. Production methods can also affect the 
properties of the engineered nanomaterials (ENs). Similar particle can exert different health 
effect. Humans can be exposed to ENs through multiple routes viz. inhalation, dermal, ingestion 
and other possible ports of entry. Hence arises the need to define a metric to measure toxicity 
taking into account all these factors. 
Identification of potential hazard associated with specific physical (i.e. size, shape, 
aggregation, and crystallinity) and chemical properties (i.e. composition, surface coatings and 
solubility) is critical in guiding safer development and use of nanotechnology. Nanomaterials 
with smaller diameters are known to have more toxicity as compared to their larger counterparts 
because it increases its chances of entering the cell. Elongated nanomaterials like rods, wires are 
known to have higher toxicity as they can easily penetrate the cell membrane. A crystalline 
material can be more toxic than amorphous materials because it has more reactive sites. Heavy 
metals are founds to be most toxic, hence knowing composition is very important. The surface 
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coating of the nanomaterial governs its affinity towards the material and agglomerated 
nanoparticles are found to have less toxicity as compared to the dispersed once. Having a 
detailed account of the characterization of nanomaterials will help be a useful step in 
understanding toxicity.  
The next study would be to understand the toxicity of nanomaterials that are used widely 
in the various industries. For example, one of the booming areas is use of nanomaterials in 
semiconductor industry. The slurry (from semiconductor industries) discharged into the waste 
streams consists of heavy doses of nanoparticles that might be toxic to the environment. Thus, 
necessity to gain fundamental understanding on interaction of engineered nanomaterials (ENs) 
with biological systems. This can help us guide development of second generation ENs with 
minimal adverse biological or health effects. In addition, nanomaterials have unique chemical 
and physical properties that are useful for various industrial and consumer applications. These 
unique properties can give rise to varying biological reactivity. This had led to an exponential 
concern over the safety of nanomaterials and the urgency to control the potential risks.  
Metal, metal oxide nanoparticles, quantum dots, fullerenes, carbon nanotubes, nanoclays 
and polymers are been tested abundantly for toxicity they might possess (5). However, some 
fundamental questions still remain to be addressed before hazard assessment. To convincingly 
provide an answer, toxicity studies should be carried on multiple cell types with different 
physicochemical properties of nanomaterials and over a relevant range of doses. Francoise 
Schrurs and Dominique Lison summarize this into six basic questions that need to be addressed  
(1) Is cytotoxicity dependent on the size of the nanoparticles? Are the NP’s more toxic 
than their larger counter parts? There is a general assumption that NP are more toxic 
than the larger sized particles, but there are very few studies that have compared the 
cytotoxic activity of nano and micrometer sized particles.  
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(2) Does the distribution profile in the biological entity and inclusion of nanoparticle in 
the cell affect the levels of toxicity? Can the nanoparticles be tracked in the cellular 
level? 
(3) There are various cell lines that are used for examining the cytotoxic activity of 
nanoparticles. Is there a variation in cytotoxic activity with cell type and if so, how 
can studies be performed? Comparison of the responses of different cell types with a 
single NP over a range of different concentrations using the same cytotoxic assay 
should be done. Critical factors causing difference in responses among different cell 
types must be identified. What is the mechanistic difference for the difference in 
toxicity response? 
(4) Does the aggregation of NP influence the cytotoxic activity? NPs have a tendency to 
aggregate and agglomerate in order to reduce their surface energy. This property 
lowers the probability of cells being exposed to single nanoparticles in the presence 
of a solvent.  To understand the effect of this parameter, the stability of nanoparticles 
in suspensions with varying influence of stabilizing agents.  
(5) What property of the NP is actually responsible for their cytotoxic activity? It is 
essential to understand why they are cytotoxic in order to design safer nanomaterials. 
The parametric effect of varying physical and chemical properties such as size, shape, 
structure, chemical composition, impurities, aggregation on cytotoxicity need to be 
understood. 
(6) What assays are actually suitable for the cytotoxic studies?  Cytotoxic assays like 
MTT are widely used. Use of positive and negative controls is a necessity in order to 
validate the assays used. 
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In this work, an attempt is made to address some of these questions. In particular, effect 
of toxicity on three compositions, three cell types, and five different concentrations are tested 
over a broad time course. The behavior of cells was analyzed over a time period of 2 weeks at 4 
different time points to study acute toxicity. 
1.3 Approach 
  Gold nanorods, silica nanoparticles and zinc oxide nanoparticles were used in this study. 
These 3 nanomaterials were selected because of their abundant use in various applications. Wide 
use of gold in various biomedical applications, silica in semiconductor industry, and zinc oxide 
in sunscreen products, textiles, paintings, industrial coatings, and antibacterial agents gives rise 
to the need of understanding their toxicity. First, a thorough characterization of these 
nanomaterials was done using methods such as dynamic light scattering, X ray diffraction, and 
scanning electron microscopy. These methods provide data about the size, shape and size 
distribution in the suspension.  
 Next, the nanoparticles were exposed to 3 different cell lines. Cell cultures were 
maintained using the standardized protocol. Fibroblasts NIH 3T3s, neuronal PC12s and Normal 
Human Bronchial Epithelial (NHBE) cells were used for cytotoxicity testing. Three different cell 
lines were used in order to see if the cytotoxicity varied with cell type. Cytotoxic assays such as  
MTT and LDH were used in order to test for cell viability and membrane integrity at 4 different 
time points. To further validate and understand the data obtained from the cytotoxic assays, the 
cells exposed to nanoparticles were imaged under the scanning electron microscope and confocal 
microscope to study cellular uptake and morphological changes that have effected upon 
exposure. 
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1.4 Thesis Organization 
   In the forthcoming chapters, literature review, materials and methods, results and 
discussions and future recommendations are discussed. Chapter 2 is literature review, which will 
discuss various toxicity studies done on different nanoparticles, how different properties of the 
nanomaterials affect the toxicity on different cell lines, and assays that are most suitable and 
abundantly used for in vitro toxicity studies. Chapter 3 discussed materials and methods of this 
work. This section will talk about the three different nanomaterials used in this study and the 
different methods used to analyze them in order to characterize them thoroughly, the cytotoxic 
assays that were done on them and the morphological changes that were observed under SEM 
and confocal microscope. Chapter 4 discusses the results with an in depth analysis of the data 
obtained. Finally, Chapter 5 will provide conclusion and recommendations for future work. 
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CHAPTER 2 
Literature Review 
2.1 Nanomaterial applications 
 Nanomaterials are widely used in engineering applications like microelectronics, 
materials, textiles, energy, healthcare and cosmetic goods. Nanotechnology applications will give 
rise to cleaner energy production, lighter and more durable materials, inexpensive clean water 
production and will benefit medical applications such as smart drugs and diagnostics.  
2.2 Nanomaterial properties and characterization techniques 
Nanomaterials might range from tens to hundreds of nanometers but as defined by the 
United States Nanotechnology Initiative, nanomaterials are materials having at least one 
dimension in the range of 1-100nm (6). Production volumes and the use of engineered 
nanomaterials in many innovative products is increasing, however little is known about their 
potential risk on the environment and human health. The main risks for human health may arise 
from chronic occupational inhalation exposure, especially during the activities of high particle 
release and uncontrolled exposure. The information on consumer and environmental exposure of 
humans is too scarce to even attempt a quantitative risk characterization. We need to identify the 
hazard first then estimate the exposure route and dosage and this should be followed by risk 
assessment (7). 
In order to study the risk imposed by the nanoparticles we need to understand what goes 
on at the nano-bio interface. At the interface between biological systems and nanomaterials, the 
organic and synthetic worlds merge into a new science which is concerned with the safe use of 
nanotechnology and nanomaterial design for biological applications (8). The most important 
nanoparticle characteristics that determine the surface properties in the medium are the material’s 
chemical composition, surface functionalization, shape, porosity and surface crystallinity, 
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heterogeneity, roughness, and  hydrophobicity or hydrophilicity (9) (10) (11). Other quantifiable 
properties, such as effective surface charge (zeta potential), particle aggregation, state of 
dispersion, stability/biodegradability, dissolution characteristics, hydration and valence of the 
surface layer, are determined by the characteristics of the suspending media, including the ionic 
strength, pH, temperature and the presence of large organic molecules (for example proteins) or 
detergents. The list of various properties that need to be assessed is mentioned in Table 1. 
 
Figure 1. Sketch shows the multidisciplinary approach for evaluating biological responses 
of ENs and identifies the critical questions that researchers are focusing on answering (12).  
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Figure 1 talks about the widely used nanoparticle characterization techniques like EDX, 
XPS, AAS, ICP, BET, SEM, TEM, AFM and DLS. Once the characterization of the 
nanomaterials is thorough then cytotoxic assays can be performed on them. Knowing the 
cytotoxic potential and the mechanism can help us design safer nanomaterials for future use. 
Table 1  
Important properties in material characterization for toxicity studies (3). 
Property Importance for toxicity testing Comments 
Particle size distribution Essential  
Degree/state of agglomeration Important  
Particle shape/shape 
distribution 
Important  
Chemical composition/purity Essential  
Solubility Essential (where applicable)  
Surface properties   
 Specific surface area/porosity Essential Surface roughness may be 
important 
 Surface chemistry/reactivity Essential  
 Surface adsorbed species Important In some cases may be the 
mechanism of toxicity (e.g. 
complement) 
 Surface charge/Zeta potential Important 
(essential under 
aqueous 
conditions) 
Especially in aqueous 
biological 
environments, may change 
according to the environment 
Physical properties Important  
 Density If applicable  
 Crystallinity If applicable  
 Microstructure If applicable  
 Optical and electronic 
 properties 
If applicable  
Bulk powder properties If applicable May be important for 
dosimetry/exposure 
Concentration Essential Can be measured as mass, 
surface area, or number 
concentrations 
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2.3 Assays for cytotoxicity 
 To assess cytotoxicity, screening assays are required (14) (15) (16). Colorimetric assays 
have been widely used to study cytotoxic effects of nanoparticles. The relatively low cost and 
ease of experimental design make these assays attractive. By using reagents that are easily 
reduced by specific cellular biomolecules to give a color change and measuring it with 
spectrophotometers, cytotoxicity can be approximated. Some of the widely used ones are 
discussed here. 
 2.3.1 Trypan Blue Exclusion assay. In this assay the treated cells are trypsinized and 
treated with trypan blue, a diazo dye which is taken up by dead cells, but excluded by live cells. 
Unstained cells thus reflect the total number of viable cells in a given culture. This method is 
advantageous because it gives the actual number of cells in comparison to the control. 
 2.3.2 Microculture Tetrazolium Assay (MTAs). These are metabolic assays that do not 
provide direct information about the cell numbers, but measures viability of a cell population 
relative to control, untreated cells. Cells whose viability is to be assessed treated with soluble 
yellow tetrazolium salts such as MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium], or MTT [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide] at 370C for 2-4 hours. During this time viable cells with 
active respiratory mitochondrial activity reduce MTT or MTS into an insoluble purple formazan 
product via mitochondrial dehydrogenases, which are then dissolved in DMSO or detergent and 
quantified on a visible light spectrophotometer. This method includes some shortcomings like, 
some cells are inefficient in processing tetrazolium salts. Also the dissolution of dye in DMSO 
might lengthen the protocol. Modification to this protocol can be made by using XTT [2,3-bis(2 
methoxy-4-nitro-5 sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide] which is 
metabolized to a water soluble product thereby eliminating the solubilization step. 
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 2.3.3 Clonogenic Assay or Colony Forming Efficiency. This assay allows assessment 
of survival and proliferation over extended periods of time. Cells are plated with very low 
density and observed for 10 days to 3 weeks and then stained with crystal violet or nuclear stains 
and quantified according to numbers and/or size. This assay is used for tracheal epithelial cells, 
A549 cells, NHBE and also keratinocyte cells. 
 2.3.4 Lactate Dehydorgenase assay. LDH is soluble cytosolic enzyme which serves as 
an indicator of lytic cell death as it is released into the extracellular medium following cellular 
membrane damage resulting from apoptosis or necrosis. This test is used to study the membrane 
integrity. This method will be further discussed in chapter 3. 
 There is huge list of genotoxic assays that can be performed in order to check gene 
mutations and chromosome damage. The most common being AMES test, chromosome 
aberration test, COMET assay, cytoinesis-blocked micronucleus assay, HPRT forward mutation 
test and 8-hydroxydeoxyguanosine DNA adducts. 
2.4 Toxicity studies done of nanoparticles 
 Literature review for all the nanomaterials that have been used in this thesis is done here. 
 2.4.1 Gold nanorods.  Gold nanoparticles have interesting physicochemical properties 
and have been in existence since Roman empire when Faraday attempted to make stable aqueous 
dispersions of gold nanoparticles. There are a lots ways of synthesizing different sizes and 
shapes using different methods (13). It has numerous applications because thiol and amine 
groups bind strongly to the gold surfaces thus enabling surface modification of gold 
nanoparticles with amino acids and proteins that leads to important biomedical applications 
ranging from bio-diagnostics, drug/DNA delivery, cell imaging, immunostaining, and biosensing 
(14). The toxicity of gold varies depending on the target and shape of the particle. 
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  Spherical gold nanoparticles of different sizes are not inherently toxic to human skin 
cells, but gold nanorods are highly toxic due to the presence of CTAB as coating material. Due 
to toxicity of CTAB, and aggregation of gold nanomaterials in the presence of cell media, it is 
demonstrated that it is difficult to understand the cytotoxicity of gold nanomaterials individually 
(15). Wang et al dispersed these nanorods in DMEM media and observed aggregation, this was 
due to the presence of sodium salts. So they prepared different solutions of sodium and no 
aggregation was observed even after 24 hours under 0.1M concentration. Their data 
demonstrated that spherical gold nanoparticles of different sizes are not inherently toxic to 
human skin cells, but gold nanorods are highly toxic due to the presence of CTAB as coating 
material. However, further PSS coated gold nanorods coated with CTAB were found to be non 
toxic. In our studies we have used god nanorods that were coated with CTAB.    
 2.4.2 Zinc oxide nanoparticles. ZnO is one commonly used nanoparticles in applications 
like sunscreen products, textile, paintings, industrial coatings and antibacterial agents (16) (17). 
Even though zinc oxide nanoparticles are believed to be non toxic (18). There are reports that 
ZnO NPs can exert negative cellular responses. Exposure to zinc oxide nanoparticles has been 
associated with cytotoxicity (19). In a study conducted by Prach et al it was shown that the 
nanoparticles had an increased cytotoxic effect as compare to their bulk counterparts (20). They 
also concluded that there is a strong association of zinc ions with proteins. Release of zinc ions 
(Zn2+) subsequently leads to oxidative stress and causes toxicity (21) (22). The shape is also 
known to affect cytotoxicity in some cases (22) (23). Mechanism for cytotoxicty by zinc oxide 
nanoparticles has been proposed by Kao et al who say that most of the damage is done to the 
mitochondrial membrane (24). In vivo studies performed by Sharma et al. show significant 
damage to liver and kidney in mice (25). A proper understanding of mechanism of zinc oxide 
NPs and cellular uptake is further needed. 
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 2.4.3 Silica nanoparticles. Silica produced on industrial scale serving as additives to 
drugs, cosmetics, printer toners, varnishes, and even food (6) (16) (26). With such a wide 
abundance it is necessary to study its cytotoxicity. Lots of cell culture systems have been used to 
investigate the cytotoxic activity of nanosilicas. Conclusions from these studies varied from dose 
(27) and size dependent cytotoxicity (28), cell line dependent toxicity (29), alterations of nuclear 
structures(30), inhibition of replication to no alteration in cell viability. It is desirable to suspend 
these nanoparticles in either serum free media or in water as particles suspended in media with 
serum will form micelles of protein around the nanoparticle, hence altering the nanoparticle 
property. Some studies used surfactants like tween and pluronic for uniform dispersion. Most 
widely used cytotoxic studies include MTT, LDH, XTT, WST 1, and trypan blue. In most of the 
studies positive and negative controls were not included. Exposure of the nanoparticles varied 
from 1-6 days. Toxicity also varied depending on the weather the particles was amorphous or 
crystalline (31). Calcium and plasma membrane cholesterol dependent uptake of nanoparticles is 
shown by Ekkapongpisit et al (32).  
2.5 Cellular uptake of nanomaterials   
Lots of attempts have been made to understand the cellular uptake of nanomaterials. The 
plasma membrane plays an important role in maintaining mechanical, chemical, osmotic and 
electrical equilibrium of cells relative to the outside. It also controls the translocation of the 
molecules in and out of the cytoplasm. Active or passive transport is usually used by the cells 
membrane to transport materials across the membrane but because the nanoparticle size is bigger 
cellular uptake by endocytosis of these nanoparticles is most likely to occur. Endocytosis can 
take place by phagocytosis (cellular eating), pinocytosis (cell drinking), and clathrin 
dependent/independent receptor mediated endocytosis (33). All these mechanisms are activated 
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differently so it is important to understand which mechanism is responsible for nanoparticle 
uptake.  
Visualization of the nanoparticles inside the cells can be performed either by light or 
electron microscopy (34).  Light microscopy has limited resolution but the nanoparticles can be 
fluorescently labeled. Stains can be used to label various organelles and can show co-localization 
of the nanoparticles. Methods like video-enhanced contrast (VEC) and differential interference 
contrast (DIC) microscopy can be used to provide information like position, motility and cell 
shape. 
The most widely used methods include sectioning of the cells using a microtome (35) and 
imaging the cells using electron microscopy (SEM or TEM). Some materials can be traced inside 
the cells while the others cant depending on the nanoparticle properties. TEM and SEM do not 
require fluorescence to visualize nanoparticles. TEM offers much better resolution than the SEM 
but also take lot of sample preparation. Biocompatible silica coated magnetic nanoparticles were 
shown to be uptaken by A549 cells under the TEM (36).  
 ICP-OES is also used for tracking the nanoparticles inside the cells. To analyze the 
samples using ICP OES the sample needs to be dissolved in nitric acid and then the sample is 
analyzed for the presence of certain elements. It is very efficient method for elemental detection. 
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CHAPTER 3 
Methodology 
3.1 Materials  
 In this chapter, we will discuss all the materials and methods that were used throughout 
this project. Cell culturing, cytotoxicity assays performed on cells, different techniques of 
characterizing the nanoparticles and analyzing the cells exposed to nanomaterials will be 
discussed. 
3.1.1 Nanoparticles. The different nanoparticles that were being used were purchased 
from Sigma Aldrich. They are Au nanorods (Product Number: 716839), Silica powder (Product 
Number: 637246) and ZnO (Product Number: 544906) powder. Gold was in suspension when 
purchased and stock solutions of the later 2 were made in water. The stock solutions of silica and 
zinc oxide were 1000 µg/ml and 200 µg/ml. 
Table 2  
Physical properties of the different nanomaterials (Particle size as given by manufacturer). 
 
Above table 2 shows the physical properties of the different nanomaterials. The size is 
that claimed by the manufacturer. The crystallinity and the surface coatings of the material are 
mentioned. Au came in colloidal suspension dispersed in water. CTAB 
(cetyltrimethylammonium bromide) was used as a stabilizer. CTAB in the suspension is less than 
0.1%. The size of these nanorods is 10 nm × 45 nm ± 10%. Silica was in powder form. The size 
and surface area as claimed by the manufacturer are 5-15nm and 590-690 m2/g. The 
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crystallographic structure is amorphous. Zinc oxide came as a powder too. The size and surface 
area as per the manufacturer is <100nm and 15-25 m2/g respectively.  
 3.1.2 Cells. Three cell lines were widely used throughout for the studies, the cell lines 
being 3T3 fibroblasts, PC12 neurons and NHBE cells that were purchased from ATCC 
(American Type Culture Collection). Fibroblasts were used mainly because they are primarily 
responsible for synthesizing the ECM of tissue, and are one of the most abundant cell lines in the 
body. They are most likely to come into contact with nanoparticles. Hence fibroblasts are widely 
studied cell lines in nanotoxicology (3). While PC12 on the other hand is a cell line derived from 
pheochromocytoma of rat adrenal medulla associated with the nervous system. PC12s are 
basically undifferentiated neurons and upon treatment with nerve growth factors they grow into 
neurons.  They are widely used because they possesses properties that make it applicable to a 
wide variety of neurobiological problems and widely used in detecting neurotoxicants. Therefore  
3t3 and PC 12 were used in this study. 
Normal Human Bronchial /Tracheal Epithelial Cells (NHBE) were also used for a study. 
These cells are usually isolated from normal donor airway epithelial tissue located above the 
bifurcation of the lungs. This is a good cell line to study the effect of inhaled nanoparticles. 
3T3 and NHBE cells have to adhere to the surface in order to grow while PC12s grow in 
suspensions without adhering to the bottom surface of the plate. But in order to carry out any 
studies on PC12s we need them to adhere to the surface. 3T3s and NHBE cells are fine but in 
order to grow PC12s we need additional material.  
3.1.3 Supplementary materials. For maintaining cells cultures aseptic conditions and 
lots of supplementary materials are required. These supplementary materials will be discussed in 
this section.  
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3.1.3.1 Poly-d-lysine. Purchased from Sigma Aldrich (Product Number: P6407). Poly-D-
lysine is a synthetic amino acid that is positively charged and widely used as a coating to 
improve cell attachment and adhesion to both plastic ware and glass surfaces. The molecular 
weight of PDL varies significantly from 30,000 Da to 300,000 Da. The molecular weight of the 
PDL we used was in the range of 70,000 to 150,000 Da providing sufficient binding sites for the 
cells to attach. There is approximately one HBr per lysine residue as seen in figure 2. The HBr 
allows the poly-D-lysine to be a crystalline solid and soluble in water.  
 
. 
Figure 2. Structure of PDL. 
Poly-D-lysine is a nonspecific attachment factor for cells useful in promoting cell 
adhesion to solid substrates. It enhances electrostatic interaction between negatively charged ions 
of the cell membrane and the culture surface.  When adsorbed to the culture surface, it increases 
the number of positively charged sites available for cell binding. 3T3 and NHBE cells as 
discussed are self-adhesive but PC-12 cells need attachment sites that are provided by PDL. 
         3.1.3.2 Trypsin. Purchased from Sigma Aldrich (Product number t4174) used to release 
adherent cells from tissue culture plates for passaging. It cleaves peptide chains mainly at 
the carboxyl side of the amino acids lysine or arginine. We need to cleave the bonds in case we 
have to passage the cells or if we want to carry out any protocol on them that need them to be in 
suspension. 
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       3.1.3.3 Dulbecco’s Phosphate Buffered Saline (DPBS). Purchased from Sigma Aldrich 
(Product number d1408) D PBS10X is a stock solution used to prepare 1X D-PBS in cell culture 
grade water. D-PBS is used to wash cells during preparation and serial transfer.  
3.2 Nanomaterial Characterization 
 Before studying the toxicity of the nanomaterials it is very important to characterize the 
nanoparticles because their toxicity varies as they are very small size. The characteristics and 
behavior are quite different to bulk materials with the same composition. The range of 
parameters that have to be assessed to characterize these materials are large but an attempt has 
been made to characterize the nanomaterial is as many different ways as possible 
 
Figure 3. Key parameters to characterize nanomaterials. 
Noted above in the figure 3 are the key parameters to characterize nanomaterials (37). 
Characterizing techniques that have been used in this study include DLS, XRD and SEM. We 
will discuss each of these in detail. 
 3.2.1 Dynamic Light Scattering. Dynamic light scattering is a technique that can be 
used to determine the size distribution profile of small particles in solution. When light hits 
particles in solution or suspension that are less than 250 nm in size, the light scatters in all 
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directions, known as Rayleigh scattering. The resultant scattered light interferes with the 
surrounding particles in a constructive or destructive manner. The light intensity fluctuation 
gives information about the aggregation and disaggregation of the particles over time.  Microtrac 
Zetatrac was used for this purpose. 
 
Figure 4. The DLS software. 
The nanoparticle stock solutions that were made in water were diluted 10 times and used 
for the DLS. 1 ml of sample was added to the sample holder for running the experiment to 
measure the particle size. The software opens up to the page shown in figure 4. In order to study 
the size distribution we need to set all the parameters right. We go to the SOP section on the top 
left of the software and set parameters like run time, number of runs, what particle we are 
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looking at and we can also check the zeta potential. Microtrac zetatrac was used just to see the 
size distribution profile. 
 3.2.2 X Ray Diffraction. For doing the crystallographic studies Xcalibur E small 
molecule diffractometer was used. Crystal structure were determined using a single wavelength 
system.  Nanocrystals diffract X rays in unique ways that can give us the crystal system of the 
material. The software for Xcalibur opens to figure 5. 
 
Figure 5. The XRD software. 
First of all the sample, in our case silica and zinc oxide powder are taken and filled into 
the capillary as uniformly as possible. This capillary is then mounted on the stage and adjusted 
so as to make sure that the X rays pass through the sample and are collected by the receiver on 
the other end. For this study Molybdenum beam was used as X ray source at 50kV and 30mA for 
zinc oxide and 15kV and 5mA for silica. Number of frames was 4 and the time of exposure was 
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60 seconds (33).  After running the sample in XRD it give us intensity and degree (2θ) values 
that will be discussed in the results section. 
  3.2.3 SEM (Scanning Electron Microscope). SEM is one of the major tools to analyze 
the shape of the nanoparticles. In the scanning electron microscope (SEM), electrons emitted by 
an electron gun are focused into a thin fine beam (2–10 nm in diameter) by a set of condenser 
lenses. The electron beam is deflected by using the scan coils in a controlled pattern so that it 
raster-scans a rectangular area where the sample is placed. The primary electrons (the incident 
beam) interact with the sample, producing secondary electrons, backscattered electrons, Auger 
electrons, X-rays and the photons. Back scattered electrons result from elastic scattering (i.e. 
with little or no change in energy) of the primary electrons, with the positive nuclei of the 
specimen. Secondary electrons are predominantly produced by the interactions of the beam 
electrons with the weakly bonded conduction-band electrons in metals, and therefore only a 
small amount of kinetic energy can be transferred to the secondary electrons; their energy in fact 
ranges from 2 to 5 eV. A comparison of images obtained with secondary electrons and with back 
scattered electrons can be extremely useful to detect intracellular uptake of NPs (3). Because we 
deal with biological samples the beam is kept as low as 1eV. 
  To prevent buildup of electrical charges, to increase thermal conduction and to improve 
secondary electrons emission, samples prepared for SEM are usually sputter coated with gold, 
and this layer, even when kept as thin as possible, slightly modifies the sample topography. 
Moreover, the ‘orange peel effect’, often observed at high resolution, does not necessarily 
correspond to the true surface of the NP. 
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Figure 6. The SEM software.  
The Auriga software opens up to the image shown in figure 6. The sample is placed on 
the puck that is usually coated with a carbon tape in order to get rid of the charge buildup. The 
sample is then mounted on the sample holder and inserted into the chamber. The source is turned 
on and parameters like gun, aperture, stage, detectors and scanning speed are set to desired 
values. By adjusting the magnification, focus and wobble in the right ratio we can capture good 
images of the nanoparticles. Both the nanoparticles and the cells exposed to different 
nanoparticles were studied under the SEM. 
3.3 Cell culture studies 
 3.3.1 Sterile techniques for cell culture. Sterile technique refers to procedures by which 
cultures may be manipulated without infecting the worker or contaminating the cultures or the 
laboratory environment. Good sterile technique is the first and most important step in ensuring 
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consistent results with cell culture. Working with cells take place within a laminar flow hood, 
either Class I (use with animal tissues), or Class II (use with human tissues). The purpose of 
these hoods is to minimize the risk of infection entering from the outside environment, as well as 
to protect the user against potential pathogens being transmitted from the culture into their 
environment. Some of the common sterile techniques followed in the labs are wiping the work 
area and hand gloves with 70% ethanol before starting the experiments, keeping sterile pipettes 
in their wrappers prior to use and not using the same pipette/pipette tips to draw media from 
different bottles. 
 3.3.2 Cell line and culture conditions.  Two cell lines were mainly used throughout the 
studies. The cell lines being 3T3 fibroblasts and PC12 neurons were fetched from 
ATCC(American Type Culture Collection). Cell cultures were maintained according to the 
standard protocol prescribed by ATCC. RPMI media is used for PC12 cells and DMEM media is 
used for 3T3 cells as seen in Table 3. The cells were maintained at 95% 02 and 5% CO2 under 
normal humidified conditions.  
Table 3  
Media Composition.  
Complete media for 3T3 Complete media for PC 12 
1% penstrap 
10% FBS 
84% DMEM media 
1% penstrap 
5% FBS 
10% Horse Equine serum 
84% RPMI media 
 
The media for NHBE cells consists of 50% DMEM and 50% BEBM.  
 3.3.3 Cell morphology. Morphological observations of cell culture were performed using 
inverted microscope. The cells were observed periodically for any changes in morphology and 
 visual indications of cellular damage. Observatio
fluorescence scope. 
Figure 7. Healthy cells (a) 3T3 (b) PC
 The figure 7 above shows the images of the healthy cells not exposed to any 
nanoparticles after one day seeding. The 3T3s and PC12s were seeded at a low density while 
NHBE cells were seeded at high density.
the PC12s grow in suspension. 
3.4 Exposure method  
 3T3 cells were cultured until they were 90
counted with a hemocytometer as seen in the figure 8
4000cells/cm2 for 24 hours before exposing them to the nanoparticles. The st
used to expose the cells after 24 hours of seeding once they were adhered to the bottom surface 
ns were recorded using the SEM and 
-12 and (c) NHBE cells. 
 The 3T3 and NHBE cells adhere to the surface while 
-95% confluent, they were then typsin
 below. They were seeded at a density of 
ock samples were 
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of the plates. The one time exposure lasted for 24 hours in all studies and the media was change 
every other day. 
 
Figure 8. Cell counting with a hemocytometer. 
 For PC-12 cells, PDL plates were first prepared. PDL at concentration of 50µg/ml was 
first added to the plated until it formed a thin uniform layer in the wells. This was left overnight 
inside the hood. After 24 hours all the PDL was removed and washes 3 times with PBS and was 
allowed to dry for 2 hours until the well were completely dry. The cell were then seeded at 
density of 10000cells/cm2 (38) (39) and then exposed to the nanoparticles at 5 different 
concentrations seen in table 4, after 24 hours once the cells were nicely adhered. 
Table 4 
 Concentration of the nanoparticles used throughout the study. 
 Au nanorods (nM) SiO2 nanoparticles 
(µg/ml) 
ZnO nanoparticles 
(µg/ml) 
Concentration 1 0.05 15 1 
Concentration 2 0.1 30 5 
Concentration 3 0.25 45 10 
Concentration 4 0.5 75 25 
Concentration 5 1 100 50 
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The stock of the particles was prepared in water for SiO2 and ZnO, whereas Au was 
purchased in suspension. The stock was sonicated for 30 minutes before exposing the cells to the 
nanoparticles in order to make sure that fewer aggregates were formed. 
3.5 Toxicity Evaluation 
 To know the adverse effects caused by a myriad of chemically and physically diverse 
nanomaterials, screening assays are required to assess the toxicity. Because of the expense of the 
in vivo assays, in vitro models are more attractive for preliminary testing of nanomaterials to 
assess their potential toxicity effects. Discussed below are two such widely used cytotoxic 
assays.  
3.5.1 Cytotoxic assays. 
 3.5.1.1 Cell viability analysis. MTT assay was used to quantitatively evaluate the  
viability of cells. The principle of MTT assay is the conversion of (3-(4,5-Dimethylthiazol)-2,5-
diphenyltetrazolium bromibe) to purple formazan crystals in the presence of mitochondrial 
reductase enzyme which is present in viable cells. The amount of formazan produced is thus 
directly proportional to cell viability and can be measured using a spectrophotometer. 
The MTT assay kit was purchased from Invitrogen. Cells were seeded with densities of 
10,000cells/cm2 and 4000cells/cm2 for PC12 and 3T3 respectively. The cells were treated with 
MTT reagent and incubated for four hours. After four hours, purple formazan crystals were 
formed. The crystals were dissolved using the MTT solvent and the absorbance was measured at 
570 nm. 
 3.5.1.2 Cellular cytotoxicity analysis. LDH assay is used to evaluate the cellular 
cytotoxicity of cells treated with different nanomaterials. Determination of lactate dehydrogenase 
(LDH) release is widely used in nanotoxicity studies. ROS generated during exposure to 
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nanoparticles will cause lipid peroxidation very often, and subsequently the lipid peroxidation 
will cause cell membrane damage and disturb the integrity of cellular membranes, leading to the 
leakage of cytoplasmic enzymes such as lactate dehydrogenase (LDH) into the media. Hence we 
can say that the more severe the damage to the cell membrane by the ROS, the higher the level of 
LDH would be in the cell media. A LDH kit is available for LDH assay. In this assay, the LDH 
released from damaged cells catalyzes the oxidation of lactate to pyruvate with simultaneous 
reduction of NAD+ to NADH. The rate of NAD+ reduction is measured as an increase in 
absorbance at 490 nm and subtracting the background at 690nm. The amount of LDH released is 
proportional to the number of cells damaged.  
 LDH assays can be performed by assessing LDH released into the media as a marker of 
dead cells or by performing lysis LDH as a marker of remaining live cells. The LDH performed 
in the studies here was done in the second way that is by lysing the cells in order to confirm the 
results obtained from MTT assay.  
 3.5.2 Absorbance measurements. Absorbance is defined as the negative logarithm of 
the ratio of transmitted light intensity through a sample to incident light intensity on the sample. 
                                          
                                         
Where Aλ= Absorbance of the sample. 
I= Intensity of light transmitted through the sample. 
I0= Intensity of light incident on the sample.  
Absorbance measurements is based on the principle of Beer-Lambert law which states 
that, when light passes through a particular sample, the absorbance is proportional to the 
concentration of light-absorbing molecules in the sample at a given wavelength. The absorbance 
plate reader was used to measure the absorbance of the sample. 
Aλ = − log10(I / I0) 
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3.5.3 Characterization techniques. 
  3.5.3.1 Sample preparation for SEM/He ion imaging. When the cells were exposed to 
the nanoparticles for desired amount of time they were fixed for imaging under the SEM. They 
were removed from the incubator and all the media was first removed and the adherent cells 
were washed with 3 times with PBS and the fixing protocol was performed. Samples for SEM 
were prepared with a 3 step procedure: fixing, washing and dehydrating. The fix consists of 25% 
of 0.4M cacodylate buffer, 12.5% of 16% formaldehyde, 10% of 25% glutaraldehyde and the 
rest is water. The cells are placed in this fix overnight, washed 3 times with water and 
dehydrated later with increasing concentrations of acetonitrile. Starting with 25 then 50, 75, 95 
and two 100% acetonitrile-water solutions for 10 minutes each. Dehydration step involves 
washing the cells with HMDS. Now the cells are ready to image under the SEM. 
 3.5.3.2 Sample preparation for fluorescent imaging. For fluorescence imaging 2 dyes 
were used.  A Molecular Probes® Image-IT® Fix-Perm kit from Life TechnologiesTM (Item # 
R37602) was used to fix the cells for staining.  The process involved adding a fixative 4% 
formaldehyde solution, washing with PBS, adding a permeabilization 0.5% Triton X-100 
solution, washing with PBS, and finally adding a blocking 3% bovine serum albumin solution.  
After fixing, two Molecular Probes® cell stains were added to the cells.  First, two drops of 
ActinGreenTM (Item # R37110) were added, allowed to incubate for 30 minutes, and then rinsed 
with PBS.  This stain dyed a protein called actin, allowing visualization of the cell membrane. 
Next, 2 drops of NucBlueTM (Item # R37606) were added and allowed to incubate for 5 minutes, 
staining the DNA and allowing visualization of the cell nucleus.  Images were captured with a 
Zeiss Axio Observer Z1, a spinning confocal disc microscope.  The microscope’s 495 nm green 
laser was used to image the cell membrane dye and the 360 nm UV laser was used to image the 
nucleus dye.  
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3.5.3.3 Inductively Coupled Plasma. Inductively coupled plasma/optical emission 
spectrometry (ICP/OES) is a powerful tool for the determination of metals in a wide variety of 
sample matrices. With this technique, liquid samples are injected into a radiofrequency (RF)-
induced argon plasma nebulizers or sample introduction techniques. With a nebulizer, the sample 
liquid is converted into an aerosol and transported to the plasma. The sample mist reaching the 
plasma is quickly dried, vaporized, and energized through collisional excitation at really high 
temperature around 10000 K. The atomic emission emanating from the plasma is viewed in 
either an axial or radial configuration, collected with a mirror or lens, and imaged onto the 
entrance slit of a wavelength selection device. Single element measurements can be performed 
cost effectively with a simple monochromator/photomultiplier tube (PMT) combination, and 
simultaneous multielement determinations are performed for up to 70 elements with the 
combination of a polychromator and an array detector. The analytical performance of such 
systems is competitive with most other inorganic analysis techniques, especially with regards to 
sample throughput and sensitivity. 
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CHAPTER 4 
Results 
In this section, processed experimental data from various methods are analyzed and 
presented in detail. Nanomaterial properties studied through the aforementioned characterization 
techniques are discussed. Data from cytotoxic assays used to study the viability of the cells are 
also presented along with morphological studies used to study the changes in structure of cells on 
exposure to nano materials. 
4.1 Nanomaterial characterization 
Characterization of the subject material is a preliminary step in studying toxicity of a 
nanomaterial owing to the large variation in functionality with physical properties.  In the 
absence of insight regarding the main parameters that affect the biological activity, general 
guidance is given that characterization of test materials should be as complete as practicable. 
Nanomaterial size, shape, dispersion, composition, and other attributes are discussed in the 
following sections. 
 4.1.1 Dynamic Light Scattering.  The size of the particle plays an important role in 
cytotoxicity as the surface area is dependent on it. Nanomaterial sizes shown below are as listed 
by the manufacturer.  
Table 5  
The physical properties of the nanomaterials. 
 
Nanomaterial Size Crystallinity 
Gold nanorods 10 by 45nm - 
Silica nanoparticles 5-15nm Amorphous 
Zinc oxide nanoparticles <100nm Crystalline 
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As discussed DLS analyzes the velocity distribution of particle movement by measuring 
dynamic fluctuations of light scattering intensity caused by the Brownian motion of the particle. 
This technique yields a hydrodynamic radius or diameter that is calculated by Stokes Einstein 
equation.   
 DLS performed on the stock solution that were suspended in ultra-pure millipore water 
gave the following results. The nanoparticles, as expected, tend to form conglomerations. 
Aggregation reduces the ability of inclusion of nanomaterials in bio-matter and thus, greatly 
reducing toxicity. The solutes present (including biomolecules) can increase particle–particle 
interactions. Because the potential for agglomerate formation increases once nanoparticles are 
introduced to a solvent, effort is taken in converting the agglomerated particles into a 
monodispersed system. Sonication and the addition of salts or surfactants are generally used in 
attempts to achieve effective dispersion. The stock solutions of the particles used in this study 
were prepared in water and then sonicated for 30 minutes before carrying out DLS experiments.  
4.1.1.1 Gold nanorods. 
 
 
Figure 9. Size distribution for Au nanorods.  
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 The gold nanorods that are pristine and uniformly distributed in suspension tend to form 
aggregates when diluted in water. Rods that are 10*45nm in size tend to form aggregates in the 
size range of 50-400nm as seen in figure 9. Agglomeration is observed even under the presence 
of stabilizing molecules such as CTAB. CTAB is shown to have additional effect on toxicity(add 
reference).  
4.1.1.2 Silica nanoparticles. 
 
 
Figure 10. Size distribution for SiO2 nanoparticles.     
 The SiO2 nanoparticles that are originally of the size 5-15nm form aggregates in the size 
range of 170-3000nm as seen in figure 10. Analysis of nanoparticles was carried out without 
addition of dispersants in order to reduce background effects.  Peaks are observed at 0.280 and 
2.3 microns. The nanoparticles weren’t dissolved in the cell culture media because presence of 
serum in media can, in some cases, have a significant effect on particle toxicity due to changes in 
agglomeration or surface chemistry (40). Fresh stocks were prepared before introduction to cell 
cultures as stock solutions experience significant changes in particle agglomeration and surface 
charge over time (41). 
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 4.1.1.3 Zinc oxide nanoparticles. ZnO stock solutions were diluted by a factor of 10 
using water. ZnO nanoparticles originally of sizes less than 100nm forms agglomerates of 
different sizes ranging from 0.144-1.944 microns with majority size distribution between 200 - 
350 nm as seen in figure 11. 
                        
Figure 11. Size distribution for ZnO nanoparticles.  
 As the size of the nanoparticle decreases, the surface area per unit volume increases and 
this decreases the particle settling velocity and hence increases its mobility, potential transport 
and bioavailability in the environment. This mobility can translate to passive transport across 
cellular membranes. There is speculation that some particular nanoparticle sizes, size ranges, or 
aspect ratios may transport across membranes more readily and the nanoparticles that cross the 
membrane are more likely to interact with the DNA, RNA, the nucleus and the organelles. In 
case these interactions take place, the likelihood of the particles being toxic is drastically 
increased (3). 
 4.1.2 SEM imaging. Nanomaterials shape heavily influence the toxicological response. 
Scanning electron microscopy is performed on all the nanoparticles in order to check its shape 
and if it is corresponds to what is claimed by the manufacturer.   
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 4.1.2.1 Gold. The images below present a comparison between nanorods as imaged under 
the Auriga and as claimed by the manufacturer, for the purpose of verification. The nanorods 
seem to be uniformly distributed in both cases. A slight variation in the dimensions of the 
nanorods was observed as seen in figure 12. This could possibly be because of the sonication that 
the nanorods experience before they are added to the cell samples.  
 
Figure 12. SEM image (a) gold nanorods as claimed by the manufacturer and (b) imaged under 
SEM. 
 The gold nanoparticles used in this study have a high aspect ratio as compared to the 
other two nanoparticles viz. silica and zinc oxide because of the fact that they are nanorods. 
Rods, tubes, needles and ribbon nanostructures have high aspect ratio and can easily puncture the 
cell membrane thus increasing the potential toxicity (3).   
 4.1.2.2 Silica. The image above shows silica nanoparticles. The nanopowder was coated 
on a carbon tape on the SEM puck and the image was taken without dispersing the nanoparticles 
in water.  
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 Figure 13. SEM imaging of silica. 
 As seen in figure 13, aggregates of silica can be seen from the image above arising due to 
absence of dispersion and sonication prior to analysis. Unlike gold nanorods, there is a large non-
uniformity in size. This lack of uniformity is seen from DLS studies as well.  
 4.1.2.3 Zinc Oxide. The zinc oxide was imaged in the similar way as silica nanoparticles 
without dispersing in water. The zinc oxide powder was place on the puck directly and imaged 
under the SEM. Lots of variations were seen and a wide range of sizes and shapes in seen in the 
following figure. 
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Figure 14. SEM imaging of zinc oxide. 
 The variations observed in shape and size of nanoparticles as seen in figure 14, reinforce 
the need to perform size distribution analysis. The toxicity of the nanomaterials vary with their 
shapes and sizes owing to variation in functionality as different shapes and sizes may have 
different mechanisms of attacking the cell, hence increasing the toxicity. 
 4.1.3 X Ray Diffraction. To further analyze the nanoparticles, X ray diffraction analysis 
was carried out. This analysis was done in order to check the crystallinity of the material. An X-
ray diffraction pattern cannot exist for an amorphous sample, but in a crystalline sample both 
phase and grain size can be determined.  
 4.1.3.1 Gold nanorods. The crystal structure for gold is unknown. To analyze the 
nanomaterial we need it be in a dry powder form, but since gold came in a suspension with very 
low concentration we could not extract enough gold from the suspension for XRD studies.  
  4.1.3.2 Zinc oxide. The zinc oxide has the 
in the plot below in figure 15. The lattice determines the 
Figure 15. XRD for zinc oxide.  
Zinc oxide is seen to have a hexagonal system. The crystal data for zinc oxide for a,b and 
c is 3.249Å , 3.249Å and 5.205Å
materials being crystalline. The motif determines the intensity of the peaks.  So the plane (101) is 
most prevalent followed by (002), (110) and so on.
 4.1.3.3 Silica.  Silica powder having size 5
powder shows a presence of one huge blunt peak. As seen from the graph 
easily say that silica is amorphous.
intensity versus 2 theta plot suggests that silica is amorphous.  
the peak, the peak we get from performing XRD does not match
 
various distinct characteristic peaks as shown 
position of the XRD peaks.
 respectively. The sharp narrow peaks are an ind
  
-15nm was used to perform XRD. The silica 
in figure 16, 
 The presence of just one blunt low intensity
As lattice defines 
 the one for crystalline silica.
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ication of the 
we can 
 peak in the 
the position of 
 
 Figure 16. XRD for Silica. 
 A crystalline material, when compared with an amorphous materia
ordered structure that may possess reactive sites making it highly reactive compound
4.2 Cytotoxicity Assays 
MTT and LDH assay: For our second objective which is to test the cytotoxicity of 
nanoparticle these assays were performed. 
yl)-2,5-diphenyl tetrazolium bromide) assay and LDH (Lactate dehydr
carried out. Five different concentrations were studied including posit
four time points. 
The negative control in our case are cells th
cells that are healthy. While positive control are the cells that are exposed to the hydrogen 
peroxide. It is know that hydrogen peroxide 
being superoxide anion and hydroxyl radical which can
cell damage or death.  
l, have a
For cell viability, MTT (3-(4,5 dimethylthiazole
ogenase) assay 
ive and negative control for
at are not treated with any nan
is one of the reactive oxygen species (ROS), others 
 cause an oxidative stress that
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 highly 
 (3). 
-2-
were 
 
oparticles, i.e. 
 can lead to 
 In all the graphs, we will usually see the trend of negative control having the most viable 
cells so it will have maximum absorbance, while hydrogen peroxide treated cells will 
healthy population and hence least absorbance. 
4.2.1 Gold nanorods. 
 4.2.1.1 PC12. Figure 17 represent the MTT and the LDH data for the PC12s. We see 
from the MTT assay data that as the concentration of gold increases the vi
decreases for 2 and 4 day time point. As we increase the time of exposure to 7 day time point we 
see almost the same trend is maintained except the 2
to recover from the oxidative stress
healthy cells, gold treated cells also have almost the same absorbance indicating almost similar
proliferation for all the samples.
Figure 17. MTT and LDH data for PC12
 
 The LDH assay supports the MTT data. 
of intact cells indicating good cell count
cell damage  that happens due to the 
eventually die and detach from the surface hence leaving just the healthy once in the well. These
 
ability of the cells 
nd
 and 3rd concentration where t
. For the 14 day time point the positive control
.   
The negative control has the maximum
. The cells from the gold treated cells show prominent 
interaction of nanoparticles with the cells and cells 
41 
have least 
he cells seem 
 has the most 
 
 
 number 
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healthy cells from the wells are lysed using the lysing solution that is provided in the kit that was 
purchased from sigma. Both the MTT and the LDH show a dose dependent toxicity.  
 4.2.1.2 3T3. Fibroblast cells are found to be more sensitive to the gold nanorods. In 
Figure 18 we see a dose dependent response of the 3T3s.  On day 2 we see all the concentrations 
of gold are seen to affect the cell proliferation in the similar way.   
 
 
Figure 18. MTT assay for 3T3. 
At 2 day time point, the cell proliferation is lost for all concentrations of gold and the 
positive control but not for the negative control.  The same trend is seen for all other time points 
except the second concentration for second time point.  Not a very smooth dose dependent 
profile is observed and cells treated with lower concentrations recover from the stress at 14 day 
time point. Concentration between 0.25-1nM are toxic to both the cell lines viz. 3T3 and PC12s. 
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 4.2.2 Zinc oxide nanoparticles
  4.2.2.1  PC12. For PC 12 we
both MTT and LDH graphs. The highest concentration of zinc oxid
be as toxic as the positive control
for both and hence least viability
dose dependent response, more the concentration 
graphs for MTT and the LDH follow the same general trend. 
 
Figure 19. MTT and LDH data for PC12
Figure 19 suggests that the number of cells are
control and it goes on reducing as the concentration goes on increasing. 
intact and are damaged the most for the positive control and a gradual dose dependent dam
cell membrane is seen for increasing toxicity of zinc oxide.
 4.2.2.2 3T3. Fibroblasts are
well. As seen from Figure 20 where 
first 3 concentrations from 1-10 µ
proliferation rate. However, for the higher 2 concentrations that is the 25 and 50 
viability falls down drastically. We see a steep dose dependent response for the fibroblast cells 
with 10 µg/ml being not so toxic while
. 
 see that zinc oxide is slightly toxic to the cells
e that is 50 µg/ml is found to 
 for all time points indicating the production of ROS is the same 
. The concentrations ranging from 1-25 µg/ml show a gradual 
of zinc oxide more is the toxicity
 
. 
 more in number and healthy for positive 
The healthy cells are 
 
 more sensitive than the PC12s to zinc oxide nanoparticles as 
the MTT assay is performed on 3T3s, the cells exposed to 
g/ml look almost as healthy as the positive control with good 
µ
 25 µg/ml being very toxic. Further studies need to be 
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 as seen in 
. Both the 
 
age to 
g/ml the cell 
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carried out in order to find out the reason behind this drastic dose dependent response. 
Mechanism of action of zinc oxide can reveal a lot of information of its toxicity. 
 
 
 
Figure 20.  MTT assay for 3T3. 
4.2.3 Silica nanoparticles. 
 4.2.3.1 PC12. The concentrations used for silica nanoparticles range from 15-100 µg/ml. 
Not much of toxicity is exhibited by the silica nanoparticles as seen in figure 21. At 2 day time 
point we see for MTT assay performed that the higher 3 doses affect the cells to certain extent 
but not the first 2 doses. At the next time point the cells tend to recover from the damage and are 
as viable as the positive control cells. For the 3rd time point silica is seen to enhance the cell 
viability and for the last time point the all the samples namely positive and the once treated with 
the silica nanoparticles are seen to have the same proliferation. 
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Figure 21. MTT and LDH data for PC12
 For LDH assay the general trend seen at individual time
really agree with the MTT assay. More studies need to be done to conclude anything about the 
cytotoxicity results obtained from the LDH assay. 
 4.2.3.2 3T3. For fibroblast cells no 
used as seen in figure 22. The 2 day time point indicates no effect on cell viability for all 5 
concentrations used between 15-
for the 4 day time point as well. For 7 and 14 
the proliferation of the cells and viability of the cells is better that the negative control.
 The possible reason for the silica not being toxic to two cells lines viz. PC12 neuronal 
cells and 3T3 fibroblast cells could be its size. The aggregation that silica nanoparticles undergo 
leads to a larger size of agglomerates and hence reduces its potential to penetrate the cell, hence 
causing minimal damage to the cell. 
 
. 
 points is the same but it does not 
 
cytotoxicity is seen for all the concentration of silica 
100 µg/ml for silica nanoparticles. The same trend is observed 
day though the silica nanoparticles tend to enhance 
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Figure 22. MTT assay for 3T3. 
 4.2.3.3 NHBE cells. Since for both 
studies were performed on normal human bronchial epithelial cells
MTT assay suggests that the silica nanoparticles we
MTT and LDH assays were performed at a 4 day time point. As seen from the graphs, both MTT 
and LDH data suggests that the cell viability was poor for NHBE cell line for both the 
concentrations viz. 30 and 75 µg/m
 
Figure 23. MTT and LDH assay for ZnO for NHBE
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4.3 Cell morphology characterization 
 4.3.1 SEM. Cells treated with different NPs were imaged under a scanning electron 
microscope. The concentrations used for qualitative studies were 0.1,0.25,0.5 nM; 5,10,25ug/ml 
and 30,45,75ug/ml for gold, silica and zinc oxide respectively. The images are in close 
agreement with the data obtained from the quantitative assay.  
             
 
 
Figure 24. Healthy PC12 cells. 
Figure 24 shows the image of healthy PC12 neuronal cells. We see that the healthy cells 
have extensions that make cell to cell contact. A monolayer of cells is observed that is grown on 
the PDL. Adhesion to the base surface via extensions can be seen prominently. These extensions 
help the PC12 cells to anchor to the surface. Once anchored they are exposed to various 
nanoparticles in order to study the toxic effect of the nanoparticles on these cells. 
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Figure 25. Healthy 3T3 cells. 
Above figure 25 shows the image of healthy 3T3 fibroblasts. We see that the healthy 
fibroblast cells have a flat elongated kind of morphology. Filopodia are structures which form at 
the cell periphery and tend to protrude outwards. They are believed to play a role in initiating 
changes in cell shape and migration. They are thought to have an important function as sensory 
structures to monitor the environment and direct polarized growth, both in fibroblasts and in 
neural growth cones. 
4.3.1.1 Gold nanorods. 
 4.3.1.1.1 PC12. The healthy PC12s assume a circular shape and have extensions between 
the cells. They also exhibit higher adherence to the surface. These extensions present in healthy 
cells are not observed in the gold treated cells. 
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Figure 26.   PC12 cells at 4 day time point. Healthy cells (a) and cells exposed to gold nanorods 
0.1nM (b), 0.25nM (c) and 0.5 nM (d). 
 In figure 26, (b) shows shriveled cells with retracted membrane protrusions are observed 
indicating the commencement of membrane ruffling. Figure C indicated the loss of surface 
protrusions and figure D shows very little cell to cell contact. All this goes hand in hand with 
The MTT assay performed. The greater the concentration of gold, the more toxic it is and the 
more morphological damage is observed. 
 4.3.1.1.2 3T3. Normal 3T3s tend to have a spread out structure with an elongated 
morphology. The 3t3 that are exposed to gold nanoparticles look highly damaged unlike healthy 
a b 
c d 
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cells. Cells were observed to have highly deformed structures on treatment with below 
mentioned concentrations of gold. 
 
 
Figure 27.   3T3 cells at 4 day time point. Healthy cells (a) and cells exposed to gold nanorods 
0.1nM (b), 0.25nM (c) and 0.5 nM (d). 
These filopodia seem to reduce in number and high membrane ruffling is observed. Cells 
in Figure B exhibit loss of flat elongated structure. Dehydration of cytoskeleton is observed in 
(c), figure 27. A lower number and visibly unhealthy cells are noticed from Figure D thus 
indicating the morphological damage undergone due to gold nanorods. 
a b 
c d 
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4.3.1.2 Zinc oxide nanoparticles. 
 4.3.1.2.1 PC12. For zinc oxide, according to the MTT assay higher toxicity is observed 
with increasing concentration to the PC12 cells.  
 
Figure 28.   PC12 cells at 4 day time point. Healthy cells (a) and cells exposed to zinc oxide 
nanoparticles 5 ug/ml (b), 10 ug/ml (c) and 25ug/ml (d). 
 Morphological changes in cells are more pronounced in (c) and (d) than in (b), fom figure 
28. The cells membranes either fuse together or they lose all the contact with their neighboring 
cells suggesting damage of cells. No changes are seen in figure (b). This data supports the data 
obtained from the MTT assay hence indicating the cells undergo morphological damages with 
increasing toxicity. 
a b 
c d 
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4.3.1.2.2 3T3. Similarly for the fibroblasts, according to MTT assay the highest two 
concentrations were found to be toxic to the cells and this is seen in figure 29. Not all the minute 
damages will be evident in the images but there are definitely some noticeable once. The flat 
spread out structure of the cytoskeleton of fibroblasts is lost and the cells look like they have lost 
their solid internal structure. The attachment of the cell to surface it grows on reduces as the 
concentration of zinc oxide increases. The morphological changes are in complete agreement 
with the MTT assay data. 
 
 
 
Figure 29.  3T3 cells at 4 day time point. Healthy cells (a) and cells exposed to zinc oxide 
nanoparticles 5 ug/ml (b), 10 ug/ml (c) and 25ug/ml (d). 
a b 
c d 
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4.3.1.3 Silica nanoparticles. 
 4.3.1.3.1. PC12. Silica being so abundant in nature one wouldn’t expect it to be toxic. 
The MTT data suggests that silica enhance the cell growth and the same is observed in SEM 
images as well. The area of cells anchoring to the surface is less, we don’t see any monolayers of 
PC12 cells. The silica nanoparticles seem to influence the growth of PC12s in a 3D pattern. Cells 
treated with silica nanoparticles look decently healthy in figure 30. 
 
 
 
Figure 30.  PC12 cells at 4 day time point. Healthy cells (a) and cells exposed to silica 
nanoparticles 30 ug/ml (b), 45 ug/ml (c) and 75ug/ml (d). 
 
  
a b 
c d 
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4.3.1.3.2. 3T3. 
 
 
Figure 31. 3T3 cells at 4 day time point. Healthy cells (a) and cells exposed to silica 
nanoparticles 30 ug/ml (b), 45 ug/ml (c) and 75ug/ml (d). 
Silica at concentrations 30,45 and 75ug/ml wasn’t found to be cytotoxic from the MTT 
assay. Similar results observed from the SEM images of silica treated cells as seen in figure 31. 
There is a slight change in the morphology of the cells but nothing significant. The cells treated 
with the silica nanoparticles have maintained good adherence to the surface and the filopodia are 
flat and elongated suggesting the cells haven’t gone much of a morphological change. 
  
a b 
c d 
 4.3.1.3.3 NHBE. 
Figure 32.  NHBE cells at 4 day time point
concentration 30 µg/ml (b) and 75
NHBE cells were just imaged under the inverted
see healthy cells and cells exposed to 2 concentration of silica. In figure (b) we see the cells die 
and detach from the surface they grow on and are seen as dark spots in the figure. More dead 
cells are observed in the figure (c) as 
 
 
 
. Healthy cells (a) and zinc oxide treated cells at
µg/ml (c). 
 microscope. In the figure 32 above,
the concentration of silica is higher.  
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4.3.2 Confocal microscopy.  Confocal microscopy was performed in order to see what 
was going on inside the cells. Scanning electron microscope give use an idea of just the surface 
but to study internal morphology we need to use fluorescence. 
 
Figure 33. Healthy 3T3 fibroblast cells at 2 day time point. 
 In fluorescence imaging two dyes were used. Actin green is used to fluoresce the actin in 
the cells that is basically a monomeric subunit of microfilaments which are a major part of the 
cells cytoskeleton and DAPI on the other hand is a fluorescent stain that strongly binds to the A-
T regions of the DNA. Figure 33 shows healthy 3T3 cells. The nanoparticles weren’t tagged in 
order to preserve their surface properties.  
 The concentrations used for these experiments were the same as the SEM and all the 
images are taken at a 4 day time point.  
  4.3.2.1 Gold nanorods. The gold nanorods exposed cells were found to be stained 
see the internal morphology of it.
Figure 34. Fluorescence images of 3T3 fibroblast 
gold nanorod at 0.1nM (b), 0.25nM (c)
The figure 34 above shows the healthy cells to be 
each other but the confluency decreases as the concentration of th
image (d) shows least cells. The 
surface they grow on. They lose
seen as we increase the concentration of gold. In the image 
cytoskeleton of the cells is lost. It shrinks and loses
with increasing concentration of gold the morphology of the 3T3s is affected 
is seen on actin.  
     
cells. Healthy cells (a) and cells 
, 0.5nM (d). 
very confluent, all the cells overlapping 
e nanoparticles increases. The  
nanoparticles exposed cells undergo stress and 
 their adhesion capabilities and hence less number of cells are 
(d) we see that majority of the 
 its structure all together. We ca
by the damage that 
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detach from the 
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 4.3.2.2 Zinc oxide nanoparticles.
tendency is seen as the gold nanorods. The 
(c) and (d) hardly show any cells. As seen in the figure 35 below
changes in the morphology but (c) and (d) appear to be undergoing a lot damage. Image (d) 
shows up just the nucleus and cytoskeleton seems to have undergone changes and no a
visible. The zinc oxide NPs are also toxic like gold nanorods the only difference being that gold 
shows a gradual increase in the toxicity while zinc oxide shows a drastic change.
Figure 35. Fluorescence images of 3T3 fibroblast cells. Healthy cells (a)
zinc oxide 5 µg/ml (b), 10 µg/ml (c)
 For zinc oxide nanoparticles almost the similar 
confluency of the cells in (a) and (b) is good whereas 
 image (b) seems to undergo no 
 and cells exposed to 
, 25µg/ml (d). 
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  4.3.2.3 Silica nanoparticles
and the same is seen in the images
Figure 36. Fluorescence images of 3T3 fibroblast cells. 
silica at 30µg/ml (b), 45µg/ml (c)
The figure 36 shows the health
silica. Not much of a difference is seen in the confluency of the images (a) through (d). Neither is 
any morphological damage evident. The
look almost the same hence supporting the data obtained from the cytotoxic assays.
.  Silica nanoparticles are not toxic as seen in previous studies 
 below.  
Healthy cells (a) and cells exposed to
 and 75µg/ml (d). 
y cells and cells treated with increasing concentrations of 
 healthy cells and the silica nanoparticles treated cells 
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 The nanoparticles were not tagged in order to preserve its surface properties. In future, 
thin sections of cells will be cut out and the nanoparticles will be tagged to see where exactly the 
nanoparticle travels inside the cell. 
4.4 Cellular Uptake Studies using ICP-OES 
 For studying nanoparticle internalization, one of techniques used includes inductively 
coupled plasma optical emission spectroscopy. 
 
Figure 37.  ICP data for 3T3 fibroblasts treated with gold nanorods(0.25nM), silica 
nanoparticles(45µg/ml) and zinc oxide(10µg/ml) nanoparticles. 
 The samples treated with various NPs were segregated in 3 parts, that is the media, 
trypsin and the cell pellet. Each of these samples was dissolved in nitric acid overnight and then 
analyzed using ICP OES. The presence of an element inside the cells will confirm NP uptake. 
Above figure 37 shows the 3T3s that were treated with all different NPs. None of them show any 
significant increase in the nanoparticle concentration inside the cells after exposure. This could 
possibly mean that the toxicity undergone by the cells exposed to gold and zinc oxide NPs is due 
to membrane damage only. 
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Figure 38. ICP data for PC12 neurons treated with gold nanorods(0.25nM), silica 
nanoparticles(45µg/ml) and zinc oxide(10µg/ml) nanoparticles. 
 Similar results were observed for PC12 cell line in figure 38. Cells post exposure did not 
show any presence of elements of nanoparticles, thus indicating no internalization of the 
nanoparticles. These are the results of acute (1 day) exposure. Further studies should be carried 
out to see the effect of chronic exposure of these nanoparticles.  
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CHAPTER 5 
Discussion and Future Research 
This study was performed in order to study the toxicity of selected nanomaterials. 
Characterization of nanoparticles, cytotoxic assays, and cellular uptake was studied. Three 
nanoparticles namely, gold nanorods, silica nanoparticles, and zinc oxide nanoparticles were 
studied. Characterization of the materials was done in order to confirm the data claimed by the 
manufacturer. Most of it was found to be in agreement with that claimed by the manufacturer. 
Techniques like dynamic light scattering, X ray diffraction, scanning electron microscope were 
used in order to characterize the materials. These materials gave us useful information like shape, 
size, size distribution, and crystallinity of the material.   
 MTT and LDH assays were performed on the cell cultures after exposing them to the 
nanoparticles to study the cell viability. Five different concentrations were used for assessing the 
toxicity of the various nanoparticles, namely 0.05,0.1,0.25,0.5 and 1 nM for gold; 
15,30,45,75,100µg/ml for silica; and 1,5,10,25,50µg/ml for zinc oxide. Three different cell lines 
were used namely neuronal PC12s, fibroblast 3T3, and Normal Human Bronchial Epithelial 
cells. The results obtained were discussed in details. 
For MTT assay performed, silica as expected wasn’t found to be toxic unlike gold and 
zinc oxide nanoparticles to PC12s and 3T3s but was toxic to the NHBE cells. Gold and zinc 
oxide on the other hand had a dose dependent toxicity. 
For gold we see a general trend of increasing cytotoxicity with increase in the 
concentration of the NPs except the second concentration of gold. The response of both the cell 
types to gold is similar except that the degree of toxicity of gold towards fibroblast is more as 
compared to the neurons. The toxicity of gold could possibly be due to its rod shape and better 
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dispersion that other two nanoparticles. The CTAB that is used for dispersion might also add to 
the toxicity. Toxicity studies using just the CTAB should be carried out. 
Zinc oxide also shows a dose dependent response for both the cells types, but unlike gold 
the transition is drastic. For 3T3’s, the first 3 doses viz. 1,5 and 10µg/ml weren’t toxic but as the 
concentration increased to 25 and 50 µg/ml all the cells exhibited steep drop in viability. 3T3s 
treated with the 25 and 50 µg/ml zinc oxide never recovered with increasing time points. PC12s 
on the other hand showed a similar drop in cell viability but at 50µg/ml. The cells were seen to 
recover from the stress they had undergone and show an increase in number at 7 and 14 days.  
Silica is found to enhance the growth of both the cell types and it is maximum on the 
seventh day. A consistent trend is seen for all the concentrations at all time-points. No 
cytotoxicity is observed, but in future it will be interesting to see if there is any toxicity at the 
genetic level. 
MTT method suffers from some minor disadvantages like metabolically inactive cells 
cannot be discriminated with dead cells, MTT solution should be protected from light even 
though it could be stored at 4°C for a maximum of one month, and cells used for MTT cannot be 
subsequently used for any other assays. So in order to validate this MTT assay, LDH assay was 
performed and in most of the cases MTT data was confirmed by the LDH data. 
The morphological changes observed after exposing the cells to the nanoparticles was 
significant. Further studies can be done by sectioning the cells using a microtome or by FIB and 
then locating the nanoparticles inside the cell. For FIB, staining the organelles is a prerequisite. 
So, post staining we can infer what part of the cell the nanoparticles travel to. 
The confocal results showed some morphological changes. With just the actin and the 
nucleus fluorescing not much could be said but organelle staining can help us infer more things. 
For further studies the sections of cells can be fluorescently tagged to locate the particles. 
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Fluorescent tagging of the particles post sectioning would give us a lot of information on the fate 
of the nanoparticle. 
In order to understand the mechanism of toxicity if would be beneficial to know if the 
particle is going inside the cell. For this inductively coupled plasma was used. The particles were 
not seen to travel inside the cells for acute exposure but more research needs to done for chronic 
exposure. 
Genotoxicity would be the next step to perform, long term toxicity can be tested and in 
vivo studies in rats/mice must be carried out. A thorough study of NHBE cells is required and 
more cell lines need to be assessed. 
Cell toxicity studies are very promising in order to know if the nanomaterial is toxic. 
There is a lot of variation of parameters of nanomaterials and modes of exposure.  There is a 
need to develop instruments to assess exposure to ENMs in the environment, validated 
methods/assays to evaluate toxicity of ENM, develop models for predicting potential impact of 
ENM on environment and human health.  
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